$MLSS

Milestone Scientific (MLSS) Stock Jumps Over 35% After Hours - Here's Why - Milestone Scientific (AMEX:MLSS)

Milestone Scientific Inc. ( NYSE:MLSS ) shares surged 35.67% in after-hours trading on Thursday, rising to $0.52. The medical device firm reported its third-quarter results showing lower costs and improved losses. Check out the current price of MLSS stock here.

Original reporting
Benzinga · Mohd Haider
Published Nov 14, 2025, 7:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 14, 2025, 8:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Milestone Scientific (MLSS) Stock Jumps Over 35% After Hours - Here's Why - Milestone Scientific (AMEX:MLSS) — source image
Decision brief

The 30-second read

$MLSSBullishMed
01

Why it matters

The earnings report acted as a catalyst for the stock's after-hours surge, reflecting investor optimism about the company's financial trajectory.

02

Market read

The news is highly relevant to MLSS and the medical device sector, potentially influencing short-term trading activity.

03

What to watch

Potential profit-taking, low liquidity, and overall market volatility could limit sustained gains; earnings improvements may not be enough to support long-term growth.

Timing: immediate

Background

Milestone Scientific reported its Q3 earnings, showing reduced costs and improved losses, which positively influenced investor sentiment.

Company-level read

Ticker impact

$MLSSBullishHigh confidence
Context

The recent surge in Milestone Scientific's stock price is driven by its quarterly earnings report showing lower costs and improved losses, which may positively influence investor sentiment.

Expected impact

short-term upward movement with potential for continued gains if earnings improvements sustain.

Evidence & confidence

The substantial after-hours jump reflects strong investor confidence based on tangible financial improvements, supported by positive earnings data and increased trading volume.

$MLSSBullishMedium confidence
Context

The news is highly relevant to MLSS as it directly pertains to its financial performance and stock movement.

Expected impact

Potential for short-term momentum; however, caution is advised due to the stock's low current price and liquidity constraints.

Evidence & confidence

While the earnings beat is positive, the stock's low price and recent volatility introduce uncertainty regarding sustained upward momentum.

Market effects

The medical device sector may experience increased investor interest, especially among companies reporting quarterly results showing cost efficiencies.

Limited regional impact; primarily affects US-based medical device stocks.

Low; the news is specific to a single company and sector.

Counterpoint

The stock's sharp rise may be a short-term overreaction; profit-taking could lead to a quick pullback.

Key entities

  • Milestone Scientific Inc.

    A medical device firm specializing in innovative dental and medical injection technologies.

Related articles

$HNGEMed

Jim Cramer says one stock hitting new highs is still a screaming buy

Jim Cramer reiterated a triple buy call on Hinge Health (HNGE) on “Mad Money” Aug. 11. The stock hit a new all-time high of $93.13 on Aug. 10 and is up about 85.83% YTD, per Yahoo Finance. Hinge reported Q2 2026 revenue of $213 million (+53% YoY), free cash flow of $99.6 million, and raised FY guidance to $856-$860 million. It also agreed to a $105 million cash acquisition (Cylinder Health) to expand into GI care.

$NVDAMed

Nvidia scales back funding guarantee for Ohio OpenAI data center, WSJ reports

Reuters, citing the WSJ, says Nvidia scaled back its funding guarantee for a proposed OpenAI data center in Ohio. Nvidia is expected to initially guarantee less than $120 billion versus $250 billion previously discussed, covering only the first phase. A deal could be signed as soon as this weekend. OpenAI and Nvidia are nearing agreement; SB Energy (SoftBank unit) would develop the 10 GW site.

$METAMed

TerraPower Signs Hyundai as EPC for Eight Natrium Reactors

TerraPower said it selected Hyundai Engineering and Construction as EPC for up to eight 345 MW Natrium reactor and energy storage plants, with Meta funding and initial deliveries as early as 2032. TerraPower also signed a term sheet with SK Innovation to pursue Korea’s first commercial Natrium plant. Separately, the DOE plans to award X-energy $1B for four 80 MW HTGRs at Dow’s Texas site.